1. Home
  2. PETZ vs EVGN Comparison

PETZ vs EVGN Comparison

Compare PETZ & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TDH Holdings Inc.

PETZ

TDH Holdings Inc.

HOLD

Current Price

$1.13

Market Cap

10.9M

Sector

Industrials

ML Signal

HOLD

Logo Evogene Ltd

EVGN

Evogene Ltd

HOLD

Current Price

$0.81

Market Cap

9.1M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
PETZ
EVGN
Founded
2002
1999
Country
China
Israel
Employees
N/A
N/A
Industry
Steel/Iron Ore
Agricultural Chemicals
Sector
Industrials
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
10.9M
9.1M
IPO Year
2017
2013

Fundamental Metrics

Financial Performance
Metric
PETZ
EVGN
Price
$1.13
$0.81
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$3.50
AVG Volume (30 Days)
5.0K
122.0K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$69.77
P/E Ratio
$6.89
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.68
$0.73
52 Week High
$1.68
$2.42

Technical Indicators

Market Signals
Indicator
PETZ
EVGN
Relative Strength Index (RSI) 56.50 36.09
Support Level $0.94 N/A
Resistance Level $1.20 $1.23
Average True Range (ATR) 0.07 0.05
MACD 0.01 -0.00
Stochastic Oscillator 79.37 25.18

Price Performance

Historical Comparison
PETZ
EVGN

About PETZ TDH Holdings Inc.

TDH Holdings Inc is engaged in the business of manufacturing and selling pet food and restaurant operations. The company has two operating segments, which include Petfood sales and the Restaurant business. It has a focus on the Restaurant business segment and generates the majority of its revenue.

About EVGN Evogene Ltd

Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment, followed by Industry.

Share on Social Networks: